small ruminants
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα

Beyond health: the economic impact of resistance

  • September 12, 2025
Facebook
Twitter
LinkedIn

Antibiotic resistance is a global problem, with serious implications for both animal and human health. However, its effects go beyond the health sector. Resistant bacteria cause significant economic losses, primarily due to increased disease incidence and reduced productivity. How does this problem specifically affect the sheep and goat sector?

 

The problem of resistance

Antibiotic resistance is a current problem and a future challenge on sheep and goat farms. It complicates the treatment of common diseases such as respiratory infections, mastitis and lameness. Beyond its health and animal welfare implications, this problem also has significant economic consequences for producers.

It is estimated that resistance can cause productivity losses of more than 15% (Herawati, O., 2023)

The origin of these losses is the increase in morbidity and mortality rates from infectious diseases.

Persistent infections reduce animal productivity, causing problems such as growth retardation, reduced fertility and low milk or meat production.

 

Fig. 1. Resistance directly affects the profitability of sheep and goat farms.

Examples of some diseases

  • Mastitis

Some studies have shown that bacteria of the genus Staphylococcus spp have developed resistance to antibiotics commonly used in livestock.
This poses a significant risk, as these are the most prevalent mastitis-causing pathogens in sheep and goats. Animals with treatment-resistant infections will have lower milk production and quality.

In a study to evaluate resistance, S. aureus was resistant to all antibiotics tested

Fig 2. Prevalence of antimicrobial resistance in mastitis-causing pathogens to various antibiotics: penicillin (P), ampicillin (AMP), amoxicillin (AML), chloramphenicol (C), streptomycin (S), tetracycline (TE), cephalothin (KF), gentamicin (CN), ciprofloxacin (CIP) and sulfamethoxazole (STX). Source: (Herawati, O., 2023)
  • Caseous lymphadenitis and abscesses:

The development of abscesses, mainly in lymph nodes, skin and viscera, is common in small ruminants. The bacteria commonly involved include Staphylococcus, Streptococcus, Corynebacterium and Pseudomonas.

Annual losses due to abscesses in small ruminants are estimated at US$17 million (Herawati, O., 2023)

Resistant strains can aggravate this disease, and the economic consequences can be considerable. Abscesses reduce the quality of the meat and can lead to the carcass being condemned at the slaughterhouse. In addition, the disease can cause emaciation, infertility and even death in affected animals. In some cases, abscesses may develop in the udder, causing a reduction in milk production (Hatem, M.E., 2013).

Fig 3. Udder abscesses affect milk production
  • E. coli:

A report by the European Food Safety Authority (EFSA) concluded that E. coli is the most significant antibiotic-resistant bacteria in sheep and goats in Europe.
This bacterium causes diarrhoea and septicaemia in lambs, so ineffective treatments will lead to significant losses by increasing mortality rates in young animals.

Link to the report: https://www.efsa.europa.eu/sites/default/files/2021-10/9977.pdf

Conclusions

Reducing and preventing antimicrobial resistance in small ruminants must be a priority, as the health and economic consequences are significant and pose a threat to the sector.

Good management practices, biosafety, diagnosis and prophylaxis are key actions to this end.

 

Article written by:
Tania Perálvarez Puerta. Global Product Manager, Small Ruminants Franchise – HIPRA

References:

Herawati, O., et al (2023) The global profile of antibiotic resistance in bacteria isolated from goats and sheep: A systematic review. Veterinary World, EISSN: 2231-0916
Hatem, M.E., et al. (2013) Bacterial abscessation in sheep and goat in Giza governorate with full antibiogram screening. Glob. Vet., 10(4): 372–381.

Previous Post

Interview at the Rabaneda Farm: a success story after several years of vaccinating against mastitis

Next Post

Key points for the diagnosis of 𝘊. 𝘢𝘣𝘰𝘳𝘵𝘶𝘴: act quickly to effectively control it

Related Posts

How can we calculate the profitability of vaccination against abortions?

Key points for the diagnosis of 𝘊. 𝘢𝘣𝘰𝘳𝘵𝘶𝘴: act quickly to effectively control it

October 21, 2025

Transmission of pathogens during milking is the main cause of mastitis in small ruminants. Improper use or malfunction of milking...

Interview at the Rabaneda Farm: a success story after several years of vaccinating against mastitis

Interview at the Rabaneda Farm: a success story after several years of vaccinating against mastitis

August 22, 2025

Mastitis represents one of the major health challenges for farms, having a serious impact on yield. To address this issue,...

CATEGORIES

  • Antibiotic reduction
  • Field experience
  • Footrot
  • Mastitis
  • Other Goats, Sheep and Lamb Diseases
  • Reproductive
  • Respiratory

NEWSLETTER

DON’T MISS ANY UPDATES ON SMALL RUMINANTS

    I have read and agree to the Privacy Policy and Basic information on Data Protection.

    ASK THE EXPERTS

    Your opinion is very important to us, so we encourage you to contact our team of experts on Small Ruminants to ask any questions or discuss any concerns you may have about sheep, goats and lambs health prevention.

      I have read and agree to the Privacy Policy and Basic information on Data Protection.

      Next Post
      How can we calculate the profitability of vaccination against abortions?

      Key points for the diagnosis of 𝘊. 𝘢𝘣𝘰𝘳𝘵𝘶𝘴: act quickly to effectively control it

      small ruminants

      Follow us

      Linkedin Youtube
      Categories
      • Antibiotic reduction
      • Field experience
      • Footrot
      • Mastitis
      • Other Goats, Sheep and Lamb Diseases
      • Reproductive
      • Respiratory

      Pages

      • Blog
      • Videos
      • About us
      • Contact

      HIPRA ©2025 All rights reserved

      • Cookie policy
      • Terms of use
      • Privacy policy
      • Cookie policy
      • Terms of use
      • Privacy policy

      Mastitis control program

      Our 6-point mastitis control program is a set of structured measures and practices, validated to improve udder health and milk quality in dairy farms.



        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our
        Privacy Policy.

        For further information, please check our detailed information on Data Protection.
        close-link
        Powered by Convert Plus

        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

        For further information, please check our detailed information on Data Protection.

        Website for veterinarians

        The contents of this website are aimed exclusively at prescribing veterinarians. By clicking on Accept you state that you are a veterinary professional. In other case, please contact a veterinarian and click on Decline.

        ACCEPT
        DECLINE

        NEWSLETTER

        Don´t miss any updates

          I have read and agree to the Privacy Policy and Basic information on Data Protection.

          Informazioni di base sulla protezione dei dati personali:

          Titolare del trattamento: LABORATORIOS HIPRA, S.A.
          Finalità: Gestione del rapporto contrattuale e/o commerciale con HIPRA, incluso l’invio di notizie, promozioni e inviti a eventi sponsorizzati da HIPRA.
          Base giuridica: Esecuzione del rapporto contrattuale e del legittimo interesse di HIPRA.
          Destinatari: Terzi a cui HIPRA ha affidato servizi di cloud computing, sicurezza, auditing, mailing, supporto tecnico e informatico, nonché società del suo gruppo.
          Diritti: Richiedere l'accesso e la rettifica o la cancellazione dei dati personali e altri diritti come spiegato nelle informazioni aggiuntive. Puoi vedere le informazioni aggiuntive dettagliate sulla protezione dei dati nella nostra Informativa sulla privacy.

          Per ulteriori informazioni, puoi consultare le nostre informazioni dettagliate sulla Protezione dei dati.

          Informations de base sur la protection des données personnelles :

          Contrôleur : LABORATORIOS HIPRA, S.A.
          Objectifs : Gérer la relation contractuelle et/ou commerciale avec HIPRA, y compris l'envoi de nouvelles, de promotions et d'invitations à des événements sponsorisés par HIPRA.
          Base légale : Exécution de la relation contractuelle et intérêt légitime d'HIPRA.
          Destinataires : Tiers auxquels HIPRA a confié le cloud computing, la sécurité, l'audit, le mailing, les aspects techniques et informatiques services de support, ainsi que les sociétés de son groupe.
          Droits : demander l'accès et la rectification ou l'effacement des données personnelles et d'autres droits comme expliqué dans les informations supplémentaires. Vous pouvez consulter les informations supplémentaires détaillées sur la protection des données dans notre Politique de confidentialité.

          Pour plus d'informations, veuillez consulter nos informations détaillées sur la protection des données. .

          Βασικές πληροφορίες προστασίας προσωπικών δεδομένων:

          Ελεγκτής: ΕΡΓΑΣΤΗΡΙΟ HIPRA, S.A.
          Σκοποί: Διαχείριση της συμβατικής ή/και επιχειρηματικής σχέσης με την HIPRA, συμπεριλαμβανομένης της αποστολής ειδήσεων, προωθήσεων και προσκλήσεων σε εκδηλώσεις που χρηματοδοτούνται από την HIPRA.
          Νόμιμη βάση: Εκτέλεση της συμβατικής σχέσης και έννομο συμφέρον της HIPRA.
          Παραλήπτες: Τρίτα μέρη στα οποία η HIPRA έχει εμπιστευθεί το cloud computing, την ασφάλεια, τον έλεγχο, την αλληλογραφία, την τεχνική και τον υπολογιστή υπηρεσίες υποστήριξης, καθώς και εταιρείες του ομίλου της.
          Δικαιώματα: Ζητήστε πρόσβαση και διόρθωση ή διαγραφή προσωπικών δεδομένων και άλλων δικαιωμάτων, όπως εξηγείται στις πρόσθετες πληροφορίες. Μπορείτε να δείτε αναλυτικές πρόσθετες πληροφορίες σχετικά με την προστασία δεδομένων στο Πολιτική Απορρήτου.

          Για περισσότερες πληροφορίες, ελέγξτε τις λεπτομερείς πληροφορίες σχετικά με την Προστασία Δεδομένων .

          Información básica sobre protección de datos:

          Responsable del tratamiento: LABORATORIOS HIPRA, S.A.
          Propósitos: Gestionar la relación contractual y comercial con HIPRA, incluido el envío de noticias, promociones e invitaciones a eventos patrocinados por HIPRA.
          Fundamentos legales: Cumplimiento de la relación contractual e interés legítimo de HIPRA.
          Destinatarios: Terceros a los que HIPRA ha encargado las tareas de computación en la nube, seguridad, auditoría, correo, servicios de soporte técnico e informático, así como empresas de su grupo.
          Derechos: Solicitar el acceso y la rectificación o eliminación de los datos personales y otros derechos, tal como se explica en la información adicional. Puede ver la información adicional detallada sobre la protección de datos en nuestra Política de Privacidad.

          Para obtener más información, consulte nuestra información detallada sobre Protección de datos.

          Basic Personal Data Protection information:

          Controller: LABORATORIOS HIPRA, S.A.
          Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
          Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
          Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
          Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

          For further information, please check our detailed information on Data Protection.